Softcare Limited, the consumer hygiene arm of Sunda Group, built a multi-billion-dollar business selling diapers, ceramics, and household goods to African families. Its rise offers a window into both the opportunities and accountability challenges facing Africa’s manufacturing champions.
The Quiet IPO
On November 10, 2025, Softcare Limited, a consumer goods company focused on African markets, opened for trading on the Hong Kong Stock Exchange and surged 40 percent above its offer price on debut. The public tranche was oversubscribed 1,813 times. By mid-December, shares remained roughly 25 percent above the HK$26.20 (approx. $3.35) IPO price. In the lead-up to the listing, the International Finance Corporation (IFC) had committed an $80 million package, $30 million in equity and a $50 million debt facility, to expand factory production lines across Kenya, Ghana, Tanzania, and Zambia.
The listed vehicle is Softcare Limited (02698.HK), the consumer goods arm of Sunda International Group, a Chinese business that has spent more than two decades building factories, distribution networks, and brands across African markets. The IPO marked more than a fundraising exercise. Investors were willing to assign a $2.2 billion valuation to a company whose growth story is tied almost entirely to African consumers—a proposition that would have seemed unconventional to many institutional investors two decades ago.
The Lagos Playbook
The foundations of this multi-billion-dollar valuation were built on the ground in West Africa.
Sunda’s founders began trading in Nigeria in the early 2000s, targeting a price point that imported hygiene products could not match. Rather than working through large national distributors, they built relationships directly with local wholesalers, shop owners, and market traders, country by country, over two decades. That network now spans 18 sales branches across 12 African countries and more than 2,500 direct wholesale partnerships.
The friction in maintaining it is real. David Omondi, a regional fleet distributor operating trucks out of Nairobi and Athi River, describes border crossings as the network’s most persistent vulnerability: “Our biggest headache isn’t the road quality, it’s the time lost at border posts like Malaba and Busia. Even with pre-cleared paperwork, a customs system outage can trap a 30-ton truck for days, instantly disrupting our delivery schedules in Kampala.” To absorb that risk, distributors maintain two to three weeks of buffer stock in destination warehouses, tying up capital in a business where margins are already thin.
That distribution network is one of the key assets underpinning the company’s appeal to investors, including the IFC. Competitors can match products more easily than they can replicate two decades of distribution relationships. Indian and Turkish manufacturers competing on price face the same barrier: distribution, not product, is what protects Softcare’s market position across the continent.
The Localisation Paradox
Softcare’s IPO prospectus makes a claim central to its appeal among impact investors and African governments: 98 percent of its African workforce is local. At the Athi River manufacturing facility in Mavoko, Machakos County, one of the largest hygiene product factories in East Africa, production lines are staffed almost entirely by Kenyan workers, and women made up a visible majority of workers on the production lines during a visit to the facility.
Outside, across a 35-acre compound undergoing expansion, forklifts beep in reverse as workers load shrink-wrapped pallets onto trucks bound for distribution points across Kenya.
But the same prospectus that highlights the 98 percent figure discloses, in its risk section, a $1.6 million shortfall in employee social insurance contributions between 2022 and 2024, describing it as a remediation matter without fully explaining whether the gap stems from unpaid contributions, underpayments, or delayed remittances. For investors, the amount is negligible against a $2.2 billion valuation. For the workers carrying it, the stakes are more immediate.
A casual worker at the facility, who asked not to be named for fear of losing their job, described the consequences from a worker’s perspective: “If a female casual worker goes into labour and finds out her employer didn’t remit her health insurance, she loses her statutory delivery cover, which is supposed to handle thousands of shillings in hospital costs.” Beyond healthcare, the worker said, missing NSSF remittances leave casual employees with little security in retirement or in the event of job loss.
Softcare did not respond to questions from The Africa Report about the nature of the shortfall or whether it has been fully remediated.
Dakar’s Regulatory Whiplash
The harder edge of the story unfolded in Senegal. In early December 2025, the country’s Pharmaceutical Regulatory Agency inspected Softcare’s factory in Sindia and found approximately 1,300 kilograms of expired raw materials, including polyethylene film used in sanitary pad production, and ordered a product withdrawal. Eight days later, the regulator reversed its decision after reviewing documentation supplied by the company, which showed the materials had not entered the production process.
The reversal quickly became a political controversy. Opposition MP Guy Marius Sagna led public rallies accusing the government of a cover-up. Consumer complaints spread across social media in Senegal and Cameroon. By March 2026, Health Minister Ibrahima Sy had concluded a formal investigation: no proven health risks to consumers, but a confirmed regulatory breach, and a documented discrepancy between the quantities of expired materials Softcare declared it had destroyed and what inspectors found on site. The regulator’s director was subsequently dismissed.
Softcare has maintained that expired materials did not enter products sold to consumers and announced legal action against those it accused of orchestrating a smear campaign. The company attributed earlier quality complaints in Cameroon to counterfeit goods circulating in the market. Responding to questions from The Africa Report about changes made to materials management since the episode, the company had not provided a statement by the time of publication.
What the episode exposed was a structural vulnerability that extends well beyond Softcare itself. A regulator identified a breach, reversed its decision after reviewing corporate documentation, and then spent months navigating public confusion over what had happened inside the factory. For a company operating across a dozen African markets, the episode highlighted the distance between institutional investor expectations and the regulatory environments in which daily production decisions are actually made.
The IFC did not respond to questions about the governance conditions attached to the investment or whether developments in Senegal have any bearing on its ongoing supervision of the company.
Power and Obligation
Softcare’s success story is difficult to dispute. Over two decades, Sunda built one of Africa’s largest consumer goods businesses by focusing on products millions of households use every day and by investing in distribution networks that many competitors overlooked.
The questions now facing the company are less about growth than governance. As Softcare expands across the continent with backing from global investors, its challenge is no longer proving that African consumer markets can support billion-dollar companies. It is demonstrating that the governance systems overseeing those companies can keep pace with their scale. That question matters for a continent seeking to build globally competitive manufacturing champions of its own.
